HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.0
  1. Home
  2. /Reaction

Acetone → HCID 67582065, compound

HRID 1416454
Notes
Print preview

Reaction equation

HRID 1416454 reaction equation
[OH:1][C@@H:2]1[CH2:6][O:5][CH2:4][C@H:3]1[O:7][C:8]1[C:17]2[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=2)[N:11]=[C:10]([N:18]2[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]2)[N:9]=1.CC(C)=[O:26]>>[C:6]([OH:26])(=[O:5])[CH3:2].[OH:1][C@@H:2]1[CH2:6][O:5][CH2:4][C@H:3]1[O:7][C:8]1[C:17]2[C:12](=[CH:13][CH:14]=[CH:15][CH:16]=2)[N:11]=[C:10]([N:18]2[CH2:19][CH2:20][NH:21][CH2:22][CH2:23]2)[N:9]=1
ParticipantsProcedureWorkupSources & evidenceReaction notes

Participants

3

Reactant 2

HCID 180AcetoneHCID 54489989HCID 54489989, compound

Product 1

HCID 67582065HCID 67582065, compound

Procedure

4-[trans-(4-Hydroxytetrahydrofuran-3-yl)oxy]-2-(1-piperazinyl)quinazoline (cf. Example 11) (200 mg) is dissolved in acetone (20 ml) with heating, and the solution is filtered, and the filtrate is concentrated and thereto is added acetic acid (50 mg), and the mixture is allowed to stand at room temperature. The precipitated crystals are separated by filtration to give 4-[trans-(4-hydroxytetrahydrofuran-3-yl)oxy]-2-(1-piperazinyl)quinazoline monoacetate (171 mg).

Workup

  1. temperaturewith heating
  2. filtrationthe solution is filtered
  3. concentrationthe filtrate is concentrated
  4. additionis added acetic acid (50 mg)
  5. customto stand at room temperature
  • customThe precipitated crystals are separated by filtration
  • Sources & evidence

    ORD record
    ord-62b23331a7244d3999cbbf9f294ee7b1
    Source dataset
    uspto-grants-1999_06
    DOI
    10.6084/m9.figshare.5104873.v1
    Patent number
    US05912247

    Reaction notes

    Loading…

    On this pageParticipantsProcedureWorkupSources & evidenceReaction notes